L-glutamine sensitizes Gram-positive-resistant bacteria to gentamicin killing

Microbiol Spectr. 2023 Dec 12;11(6):e0161923. doi: 10.1128/spectrum.01619-23. Epub 2023 Oct 26.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) infection severely threatens human health due to high morbidity and mortality; it is urgent to develop novel strategies to tackle this problem. Metabolites belong to antibiotic adjuvants which improve the effect of antibiotics. Despite reports of L-glutamine being applied in antibiotic adjuvant for Gram-negative bacteria, how L-glutamine affects antibiotics against Gram-positive-resistant bacteria is still unclear. In this study, L-glutamine increases the antibacterial effect of gentamicin on MRSA, and it links to membrane permeability and pH gradient (ΔpH), resulting in uptake of more gentamicin. Of great interest, reduced reactive oxygen species (ROS) by glutathione was found under L-glutamine treatment; USA300 becomes sensitive again to gentamicin. This study not only offers deep understanding on ΔpH and ROS on bacterial resistance but also provides potential treatment solutions for targeting MRSA infection.

Keywords: L-glutamine; ROS; gentamicin; membrane permeability; methicillin-resistant Staphylococcus aureus; ΔpH.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Gentamicins* / pharmacology
  • Glutamine
  • Gram-Positive Bacteria
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests
  • Reactive Oxygen Species

Substances

  • Gentamicins
  • Glutamine
  • Reactive Oxygen Species
  • Anti-Bacterial Agents